Literature DB >> 7783064

Muscle strength assessment in polymyositis and dermatomyositis evaluation of the reliability and clinical use of a new, quantitative, easily applicable method.

T Stoll1, P Brühlmann, G Stucki, B Seifert, B A Michel.   

Abstract

OBJECTIVE: To evaluate the feasibility and the reliability of a quantitative method of maximal isometric strength measurement for the assessment of patients with myositis in clinical practice and research.
METHODS: Three observers independently examined the strength of 13 muscle groups of 7 patients with stable polymyositis and dermatomyositis (PM/DM) using a handheld pull-gauge. Reliability was assessed following a balanced random 3-way cross classification with interactions and using the analysis of variance method. Serial followup strength data for 2 patients were compared to change in creatinine kinase (CK) levels.
RESULTS: All measurements could be performed without causing pain to the patients. One single test including 13 muscle groups was done in 7 min or less. Both intra and interobserver correlations were strong and significant for all muscle groups. The intraobserver reliability ranged from 0.88 for elbow extensors to 0.98 for knee extensors and cervical spine flexors. The interobserver reliability ranged from 0.81 for elbow flexors to 0.98 for knee extensors and cervical spine flexors. The followup of 2 cases yielded moderate to strong correlations of serial strength measurements with CK levels.
CONCLUSION: Serial measurement of isometric muscle strength with a handheld pull-gauge is a feasible, inexpensive, time efficient and reliable method and may provide additional quantitative information in the clinical assessment of patients with myositis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7783064

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  9 in total

Review 1.  Update on outcome assessment in myositis.

Authors:  Lisa G Rider; Rohit Aggarwal; Pedro M Machado; Jean-Yves Hogrel; Ann M Reed; Lisa Christopher-Stine; Nicolino Ruperto
Journal:  Nat Rev Rheumatol       Date:  2018-04-12       Impact factor: 20.543

Review 2.  Ultrasound in the evaluation of the inflammatory myopathies.

Authors:  Ronald S Adler; Giovanna Garofalo
Journal:  Curr Rheumatol Rep       Date:  2009-08       Impact factor: 4.592

Review 3.  Assessment of Physical Activity and Muscle Function in Adult Inflammatory Myopathies.

Authors:  William J Gregory; Didem Saygin
Journal:  Curr Rheumatol Rep       Date:  2022-03-04       Impact factor: 4.592

4.  Distribution and severity of weakness among patients with polymyositis, dermatomyositis and juvenile dermatomyositis.

Authors:  M O Harris-Love; J A Shrader; D Koziol; N Pahlajani; M Jain; M Smith; H L Cintas; C L McGarvey; L James-Newton; A Pokrovnichka; B Moini; I Cabalar; D J Lovell; R Wesley; P H Plotz; F W Miller; J E Hicks; L G Rider
Journal:  Rheumatology (Oxford)       Date:  2008-12-11       Impact factor: 7.580

5.  Lower extremity peak force and gait kinematics in individuals with inclusion body myositis.

Authors:  Todd E Davenport; Kimberly Benson; Stephanie Baker; Christopher Gracey; Goran Rakocevic; Beverly McElroy; Marinos Dalakas; Joseph A Shrader; Michael O Harris-Love
Journal:  Arthritis Care Res (Hoboken)       Date:  2015-01       Impact factor: 4.794

Review 6.  Measures of adult and juvenile dermatomyositis, polymyositis, and inclusion body myositis: Physician and Patient/Parent Global Activity, Manual Muscle Testing (MMT), Health Assessment Questionnaire (HAQ)/Childhood Health Assessment Questionnaire (C-HAQ), Childhood Myositis Assessment Scale (CMAS), Myositis Disease Activity Assessment Tool (MDAAT), Disease Activity Score (DAS), Short Form 36 (SF-36), Child Health Questionnaire (CHQ), physician global damage, Myositis Damage Index (MDI), Quantitative Muscle Testing (QMT), Myositis Functional Index-2 (FI-2), Myositis Activities Profile (MAP), Inclusion Body Myositis Functional Rating Scale (IBMFRS), Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI), Cutaneous Assessment Tool (CAT), Dermatomyositis Skin Severity Index (DSSI), Skindex, and Dermatology Life Quality Index (DLQI).

Authors:  Lisa G Rider; Victoria P Werth; Adam M Huber; Helene Alexanderson; Anand Prahalad Rao; Nicolino Ruperto; Laura Herbelin; Richard Barohn; David Isenberg; Frederick W Miller
Journal:  Arthritis Care Res (Hoboken)       Date:  2011-11       Impact factor: 4.794

7.  Manual muscle testing and hand-held dynamometry in people with inflammatory myopathy: An intra- and interrater reliability and validity study.

Authors:  Pierrette Baschung Pfister; Eling D de Bruin; Iris Sterkele; Britta Maurer; Rob A de Bie; Ruud H Knols
Journal:  PLoS One       Date:  2018-03-29       Impact factor: 3.240

8.  Myostatin and markers of bone metabolism in dermatomyositis.

Authors:  Katharina Kerschan-Schindl; Wolfgang Gruther; Ursula Föger-Samwald; Christine Bangert; Stefan Kudlacek; Peter Pietschmann
Journal:  BMC Musculoskelet Disord       Date:  2021-02-05       Impact factor: 2.362

Review 9.  Proposal for a Candidate Core Set of Fitness and Strength Tests for Patients with Childhood or Adult Idiopathic Inflammatory Myopathies.

Authors:  Djamilla K D van der Stap; Lisa G Rider; Helene Alexanderson; Adam M Huber; Bruno Gualano; Patrick Gordon; Janjaap van der Net; Pernille Mathiesen; Liam G Johnson; Floranne C Ernste; Brian M Feldman; Kristin M Houghton; Davinder Singh-Grewal; Abraham Garcia Kutzbach; Li Alemo Munters; Tim Takken
Journal:  J Rheumatol       Date:  2015-11-15       Impact factor: 4.666

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.